drugset / Trial / NCT00761202

Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

NCT00761202

Phase 4 Completed 50 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the performance and acceptance of Optive versus Hylocomod eyedrops, when administered for one month to patients with mild to moderate dry eye symptoms, with and without contact lenses.

Timeline

Start
2007-08
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Optive Eyedrops Unknown
Comparator Sodium Hyaluronate Other / unclassified

Indications